These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1961740)

  • 21. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture.
    Lenich C; Pannell R; Gurewich V
    Thromb Haemost; 1995 Aug; 74(2):698-703. PubMed ID: 8585009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of bismuth subgallate and adrenaline paste upon operating time and operative blood loss in tonsillectomy.
    Callanan V; Curran AJ; Smyth DA; Gormley PK
    J Laryngol Otol; 1995 Mar; 109(3):206-8. PubMed ID: 7745335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of expression of monocyte interleukin-1 by inhibitors of Hageman factor (factor XII).
    Ratnoff OD; Voytus JA; Toossi Z
    J Lab Clin Med; 1995 Feb; 125(2):247-50. PubMed ID: 7844472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
    Joseph K; Shibayama Y; Ghebrehiwet B; Kaplan AP
    Thromb Haemost; 2001 Jan; 85(1):119-24. PubMed ID: 11204562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amidolytic properties of single-chain activated Hageman factor.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1461-3. PubMed ID: 286331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII).
    Griffin JH; Beretta G
    Adv Exp Med Biol; 1979; 120B():39-51. PubMed ID: 517240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Isolation and some properties of Hageman factor and its active fragment from human blood].
    Krizhevskaia IuV; Iarovaia GA; Dotsenko VL; Khvatov VB
    Biokhimiia; 1981 Aug; 46(8):1510-8. PubMed ID: 7272366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the activation of Hageman factor (factor XII) by complement subcomponent C1q.
    Rehmus EH; Greene BM; Everson BA; Ratnoff OD
    J Clin Invest; 1987 Aug; 80(2):516-21. PubMed ID: 3038961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumption of Hageman factor activity in the generalized Shwartzman reaction induced by liquoid. Its prevention by inhibition of Hageman factor activation.
    Müller-Berghaus G; Lasch HG
    Thromb Diath Haemorrh; 1970 May; 23(2):386-404. PubMed ID: 5426216
    [No Abstract]   [Full Text] [Related]  

  • 33. The IgE-dependent release of a Hageman factor cleaving factor from human lung.
    Meier HL; Flowers B; Silverberg M; Kaplan AP; Newball HH
    Am J Pathol; 1986 Apr; 123(1):146-54. PubMed ID: 3634571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta 2-glycoprotein I and anti-beta 2-glycoprotein I.
    Schousboe I; Rasmussen MS
    Thromb Haemost; 1995 May; 73(5):798-804. PubMed ID: 7482406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
    Ratnoff OD; Saito H
    J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of chemical modification of basic amino acid residues on the activation and amidolytic activity of Hageman factor (factor XII).
    Ryder J; Everson B; Jentoft J; Ratnoff OD
    J Lab Clin Med; 1993 Dec; 122(6):697-702. PubMed ID: 8245689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection by fluorescence of structural changes accompanying the activation of Hageman factor (factor XII).
    Fair BD; Saito H; Ratnoff OD; Rippon WB
    Proc Soc Exp Biol Med; 1977 Jun; 155(2):199-202. PubMed ID: 866349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.